Candidates and resources for primary prevention of type 2 diabetes. Estimation from longitudinal data on medical checkups and later medical expenditure calculated using medical care health insurance claims

Journal of the Japan Diabetes Society

Volumn 48, Issue 12, 2005, Pages 841-847

  Hidaka, Hideki ^a   Tsujinaka, Katsumasa ^a   Yamasaki, Yoshimitsu ^b  

^a SANYO ELECTRIC CO LTD   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; COST EFFECTIVENESS ANALYSIS; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEALTH INSURANCE; HIGH RISK PATIENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIMARY PREVENTION; RESOURCE MANAGEMENT; RISK REDUCTION;

EID: 32844459831     PISSN: 0021437X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. http://www.mhlw.go.jp/shingi/2003/08/s0806-4.html
2. http://www.mhlw.go.jp/toukei/saikin/hw/k-iryohi/02/index. html
3. King H, Aubert RE, Herman WH (1998) Global Burden of Diabetes, 1995-2025. Diabetes care 21: 1414-1431
4. WHO (1994) Techinical Report: Prevention of Diabetes Mellitus WHO, Geneva, (WHO 1994)
5. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Aunola S, Cepaitis Z, Moltchanov V, Hakumaki M, Mannelin M, Martikkala V, Sundvall J, Uusitupa M, the Finnish Diabetes Prevention Study Group (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-1350
6. DPP Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403
7. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359: 2072-2077
8. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L (2004) XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27: 155-161
9. ADA (2003) Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Care 26: 3160-3167
10. Izumi Y, Tsuji I, Ohkubo T, Kuwahara A, Nishio Y, Hisamichi S (2001) Impact of smoking habit on medical care use and its costs: a prospective observation of National Health Insurance beneficiaries in Japan. Int J Epidemiol 30: 616-621
11. (IDF/WHO A Report of the Diabetes Health Economics Study Group (1997) The Economics of Diabetes and Diabetes Care. WHO, Geneva)
12. DPP Research Group (2003) Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care 26: 36-47
13. DPP Research Group (2005) The Cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 142: 323-332